.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Understanding cochlear implant research attrition is essential for maintaining the integrity of long-term clinical trials and improving patient outcomes. A recent retrospective review examined why adult cochlear implant (CI) recipients withdraw from repeated-measures studies. Researchers analyzed a sample of 118 participants to identify sociodemographic and audiologic factors associated with study completion. Consequently, the findings provide a roadmap for enhancing participant retention in future clinical investigations.
The study identified a 21% attrition rate over a 12-month period. Interestingly, sociodemographic factors such as age, race, biological sex, and socioeconomic position were similar between the groups. However, audiologic differences were significant. Specifically, participants in the withdrawal group demonstrated poorer low-frequency acoustic hearing thresholds. Furthermore, they experienced greater tonotopic mismatch compared to those who completed the research. These results suggest that baseline audiologic status may predict a participant's ability or willingness to adhere to rigorous research protocols.
Early clinical performance emerged as a primary driver of retention. Participants who remained in the study achieved significantly higher early CNC word recognition scores than those who dropped out. Therefore, patients who perceive a faster or greater initial benefit from their device are more likely to stay engaged. Additionally, individuals using electric-acoustic stimulation (EAS) were more persistent than those using CI alone. This trend likely reflects the better unaided thresholds and performance advantages inherent in EAS technology. Researchers must account for these performance disparities when designing study inclusion criteria.
To reduce cochlear implant research attrition, clinicians and researchers must reflect on these withdrawal patterns. Intentionally designing study procedures that support a representative sample is crucial. Moreover, providing additional support or more flexible scheduling for those with poorer early speech recognition may improve retention rates. Addressing these barriers ensures that clinical research remains inclusive and the data remains representative of the broader CI population.
Recent data indicates an attrition rate of approximately 21% in long-term, repeated-measures clinical research involving cochlear implant recipients. Identifying those at risk of withdrawal early is key to maintaining study power.
Participants with poorer low-frequency acoustic hearing and higher tonotopic mismatch are significantly more likely to leave a study. These variables often correlate with overall satisfaction and device use time.
Early performance is a strong predictor of persistence. Participants with better initial CNC word recognition scores are more likely to complete long-term research than those who struggle early on.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional healthcare consultation. Always seek the advice of a qualified health provider regarding medical conditions. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A retrospective review identifies audiologic and performance variables as key drivers of participant attrition in long-term cochlear implant research....
7 months ago
Recent epidemiological data reveals a dramatic surge in summer heat mortality driven by human-induced climate warming. This analysis explores the pathophysiological impacts on cardiac and renal systems, diagnostic dilemmas in death certification, and essential emergency cooling protocols for acute clinical care.
Today
Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today
India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today
A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
